Search results for "probiotic"

showing 10 items of 200 documents

The Impact of Lactobacillus casei on the Composition of the Cecal Microbiota and Innate Immune System Is Strain Specific

2016

The probiotic function to impact human health is thought to be related to their ability to alter the composition of the gut microbiota and modulate the human innate immune system. The ability to function as a probiotic is believed to be strain specific. Strains of Lactobacillus casei are commonly utilized as probiotics that when consumed alter the composition of the gut microbiota and modulate the host immune response. L. casei strains are known to differ significantly in gene content. The objective of this study was to investigate seven different L. casei strains for their ability to alter the murine gut microbiota and modulate the murine immune system. C57BL/6 mice were fed L. casei strai…

0301 basic medicineMalelcsh:MedicineGene ExpressionGut floraImmune ReceptorsBiochemistrylaw.inventionProbioticfluids and secretionslawLactobacillusMedicine and Health Scienceslcsh:ScienceCecumToll-like ReceptorsMultidisciplinaryImmune System Proteinsbiologydigestive oral and skin physiologyPattern recognition receptorGenomicsLacticaseibacillus caseiMedical MicrobiologyAnatomyResearch ArticleSignal TransductionLactobacillus casei030106 microbiologyImmunologyMicrobial Genomicsdigestive systemMicrobiologyMicrobiology03 medical and health sciencesImmune systemSpecies SpecificityGeneticsAnimalsHumansMicrobiomeInnate immune systemBacteriaProbioticslcsh:RGut BacteriaOrganismsBiology and Life SciencesProteinsCell Biologybiology.organism_classificationImmunity InnateGastrointestinal MicrobiomeGastrointestinal TractMice Inbred C57BLLactobacillus030104 developmental biologyImmunologylcsh:QMicrobiomeDigestive SystemPLoS ONE
researchProduct

Effect of a Nutritional Intervention on the Intestinal Microbiota of Vertically HIV-Infected Children: The Pediabiota Study

2020

This article belongs to the Special Issue Role of Prebiotics and Probiotics in Health and Disease.

0301 basic medicineMalemedicine.medical_specialtyChildren and adolescentsTime FactorsHuman immunodeficiency virus (HIV)HIV Infectionslcsh:TX341-641Diseasemedicine.disease_causedigestive systemArticle03 medical and health sciences0302 clinical medicineDouble-Blind MethodIntervention (counseling)Internal medicineHiv infectedmedicinemicrobiotaHumans030212 general & internal medicineChildSymbiosisNutrition and Dieteticsbusiness.industryMicrobiotaProbioticsHIVInfectious Disease Transmission VerticalGastrointestinal MicrobiomePilots030104 developmental biologyPrebioticsAnti-Retroviral Agentschildren and adolescentsChild PreschoolDietary SupplementsVertical transmissionDysbiosisFemalevertical transmissionbusinessChild Nutritional Physiological Phenomenalcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct

Helminths, hosts, and their microbiota: new avenues for managing gastrointestinal helminthiases in ruminants

2020

Evidence is emerging of complex interactions occurring between gastrointestinal (GI) parasites of ruminants and the resident gut flora, with likely implications for the pathophysiology of worm infection and disease. Similarly, recent data point toward the occurrence of a GI nematode (GIN)-specific microbiota, with potential roles in worm fundamental physiology and reproduction. Parasite-microbiota relationships might represent potential targets for the development of novel parasiticides.In this article, we review current knowledge of the role(s) that host- and helminth-associated microbiota play in ruminant host-parasite relationships, and outline potential avenues for the control of GIN of…

0301 basic medicineMicrobiology (medical)030106 microbiologyGut floraMicrobiologyHost-Parasite InteractionsMicrobiology03 medical and health sciences0302 clinical medicineDrug DevelopmentHelminthsVirologyparasitic diseasesAnimalsHelminths030212 general & internal medicineMicrobiomeAnthelminticsbiologyProbioticsGastrointestinal MicrobiomeRuminantsbiology.organism_classificationGastrointestinal MicrobiomePrebioticsInfectious DiseasesDrug developmentHelminthiasis AnimalHaemonchus contortusExpert Review of Anti-infective Therapy
researchProduct

Fermentation of Nocellara Etnea table olives by functional starter cultures at different low salt concentrations

2018

Nocellara Etnea is one of the main Sicilian cultivars traditionally used to produce both olive oil and naturally fermented table olives. In the present study, the effect of different salt concentrations on physico-chemical, microbiological, sensorial, and volatile organic compounds (VOCs) formation was evaluated in order to obtain functional Nocellara Etnea table olives. The experimental design consisted of 8 treatments as follow: fermentations at 4, 5, 6, and 8% of salt with (E1-E4 samples) and without (C1-C4 samples) the addition of starters. All the trials were carried out at room temperature (18 +/- 2 degrees C) and monitored for an overall period of 120 d. In addition, the persistence …

0301 basic medicineMicrobiology (medical)Agriculture and Food SciencesLactobacillus paracaseiVOLATILE COMPOUNDS030106 microbiologylcsh:QR1-502LACTIC-ACID BACTERIAPROFILEMicrobiologylcsh:Microbiologylaw.invention03 medical and health sciencesProbioticchemistry.chemical_compoundAcetic acid0404 agricultural biotechnologyStarterLACTOBACILLUS-PLANTARUMlawNaCl content; Probiotic strain; metabolomics microbiota REP-PCR analysismicrobiotaPhenolsFood scienceTOLERANCEREP-PCR analysismicrobiota REP-PCR analysisbiologyChemistrySTRAINSfood and beveragesProbiotic strain04 agricultural and veterinary sciencesSettore AGR/15 - Scienze E Tecnologie Alimentaribiology.organism_classification040401 food sciencemetabolomicsLactic acidNaCl contentprobiotic strainSURVIVALNaCl content probiotic strain metabolomics microbiota REP-PCR analysisFermentationPENTOSUSNACL REDUCTIONEMPHASISMesophile
researchProduct

The Gut Microbiota in Cardiovascular Disease and Arterial Thrombosis

2019

The gut microbiota has emerged as a contributing factor in the development of atherosclerosis and arterial thrombosis. Metabolites from the gut microbiota, such as trimethylamine N-oxide and short chain fatty acids, were identified as messengers that induce cell type-specific signaling mechanisms and immune reactions in the host vasculature, impacting the development of cardiovascular diseases. In addition, microbial-associated molecular patterns drive atherogenesis and the microbiota was recently demonstrated to promote arterial thrombosis through Toll-like receptor signaling. Furthermore, by the use of germ-free mouse models, the presence of a gut microbiota was shown to influence the syn…

0301 basic medicineMicrobiology (medical)CellDiseaseReview030204 cardiovascular system & hematologyGut floraarterial thrombosisMicrobiologydigestive systemlaw.invention03 medical and health sciencesProbiotic0302 clinical medicinelawcardiovascular diseaseVirologyMedicinevascular inflammationbiologygut microbiotabusiness.industryCell adhesion moleculeblood pressure regulationReceptor signalingbiology.organism_classificationmedicine.diseaseThrombosis030104 developmental biologymedicine.anatomical_structureImmunologyImmune reactionbusinessMicroorganisms
researchProduct

Probiotic yeast Kluyveromyces marxianus CIDCA 8154 shows anti-inflammatory and anti-oxidative stress properties in in vivo models.

2015

Inflammatory bowel diseases (IBDs) are complex affections with increasing incidence worldwide. Multiple factors are involved in the development and maintenance of the symptoms including enhanced oxidative stress in intestinal mucosa. The conventional therapeutic approaches for IBDs are based on the use anti-inflammatory drugs with important collateral effects and partial efficacy. In the present work we tested the anti-inflammatory capacity of Kluyveromyces marxianus CIDCA 8154 in different models. In vitro, we showed that the pretreatment of epithelial cells with the yeast reduce the levels of intracellular reactive oxygen species. Furthermore, in a murine model of trinitro benzene sulfon…

0301 basic medicineMicrobiology (medical)Malemedicine.drug_class030106 microbiologyBiologymedicine.disease_causeMicrobiologyAnti-inflammatoryMicrobiologylaw.invention03 medical and health sciencesProbioticKluyveromycesMiceIntestinal mucosaKluyveromyces marxianusIn vivolawKluyveromycesmedicineAnimalsHumansCaenorhabditis eleganschemistry.chemical_classificationReactive oxygen speciesMice Inbred BALB CProbioticsAnti-Inflammatory Agents Non-Steroidalbiology.organism_classificationColitisOxidative StresschemistryCaco-2 CellsReactive Oxygen SpeciesHT29 CellsOxidative stressBeneficial microbes
researchProduct

Identification of a Peptide Produced by Bifidobacterium longum CECT 7210 with Antirotaviral Activity

2016

Rotavirus is one of the main causes of acute diarrhea and enteritis in infants. Currently, studies are underway to assess the use of probiotics to improve rotavirus vaccine protection. A previous work demonstrated that the probiotic strain Bifidobacterium longum subsp. infantis CECT 7210 is able to hinder rotavirus replication both in vitro and in vivo. The present study takes a systematic approach in order to identify the molecule directly involved in rotavirus inhibition. Supernatant protease digestions revealed both the proteinaceous nature of the active substance and the fact that the molecule responsible for inhibiting rotavirus replication is released to the supernatant. Following pur…

0301 basic medicineMicrobiology (medical)RotavirusBifidobacterium longummedicine.medical_treatment030106 microbiologylcsh:QR1-502PeptideBiologymedicine.disease_causeMicrobiologylcsh:Microbiologylaw.inventionMicrobiology03 medical and health sciencesProbioticfluids and secretionslawRotavirusmedicineB. longum subsp. infantis CECT 7210Original Researchchemistry.chemical_classificationProteaseMolecular massProbiotics11-mer peptidebiology.organism_classificationRotavirus vaccineIn vitroProteaseBiochemistrychemistryFrontiers in Microbiology
researchProduct

Time Series Analysis of the Microbiota of Children Suffering From Acute Infectious Diarrhea and Their Recovery After Treatment

2018

WOS: 000434952800001

0301 basic medicineMicrobiology (medical)Rotavirusmedicine.medical_specialtytemporal analysis030106 microbiologylcsh:QR1-502acute infectious diarrheaDiseaseGut floramedicine.disease_causeMicrobiologylcsh:Microbiologylaw.invention03 medical and health sciencesProbioticAcute infectious diarrhealawInternal medicineRotavirusmedicinemicrobiotaFecesOriginal Researchbiologybusiness.industryMicrobiotasystems biologyTemporal analysisbiology.organism_classificationmedicine.diseaseDiarrhea030104 developmental biologyrotavirusmedicine.symptombusinessSystems biologyDysbiosisSaccharomyces boulardiiFrontiers in Microbiology
researchProduct

Milk and blood biomarkers associated to the clinical efficacy of a probiotic for the treatment of infectious mastitis

2016

Previous studies have shown the efficacy of oral administration of selected lactobacilli strains to treat mastitis. The objective of this study was to find microbiological, biochemical and/or immunological biomarkers of the probiotic effect. Women with (n=23) and without (n=8) symptoms of mastitis received three daily doses (109 cfu) of Lactobacillus salivarius PS2 for 21 days. Samples of milk, blood and urine were collected before and after the probiotic intervention, and screened for a wide spectrum of microbiological, biochemical and immunological parameters. In the mastitis group, L. salivarius PS2 intake led to a reduction in milk bacterial counts, milk and blood leukocyte counts and i…

0301 basic medicineMicrobiology (medical)UrinalysisAdministration OralMastitisUrineUrinalysisMicrobiologylaw.invention03 medical and health sciencesProbioticOral administrationlawHumansMedicineMilk Humanbiologymedicine.diagnostic_testbusiness.industryProbioticsLactobacillus salivariusfood and beveragesInterleukinbiology.organism_classificationmedicine.diseaseLactobacillus salivariusMastitisTreatment OutcomeBloodMilk030104 developmental biologyImmunologyLigilactobacillus salivariusbiology.proteinFemaleAntibodybusinessBiomarkersBlood Chemical AnalysisBeneficial Microbes
researchProduct

Topic Application of the Probiotic Streptococcus dentisani Improves Clinical and Microbiological Parameters Associated With Oral Health

2020

Streptococcus dentisani 7746, isolated from dental plaque of caries-free individuals, has been shown to have several beneficial effects in vitro which could contribute to promote oral health, including an antimicrobial activity against oral pathogens by the production of bacteriocins and a pH buffering capacity through ammonia production. Previous work has shown that S. dentisani was able to colonize the oral cavity for 2–4 weeks after application. The aim of the present work was to evaluate its clinical efficacy by a randomized, double-blind, placebo-controlled parallel group study. Fifty nine volunteers were enrolled in the study and randomly assigned to a treatment or placebo group. The …

0301 basic medicineMicrobiology (medical)medicine.medical_specialtySalivadental plaque030106 microbiologyImmunologylcsh:QR1-502Oral HealthDental CariesOral healthPlaceboDental plaqueMicrobiologyGastroenterologyPlacebo grouplcsh:Microbiologylaw.inventionStreptococcus mutans03 medical and health sciencesProbioticCellular and Infection MicrobiologybacteriocinlawInternal medicinemedicineHumansSalivasalivary flowOriginal Researchbusiness.industryProbioticsStreptococcusAntimicrobialmedicine.disease030104 developmental biologyInfectious DiseasesbusinessprobioticStreptococcus dentisaniFrontiers in Cellular and Infection Microbiology
researchProduct